Bereitschaftspotential preceding eyelid blinks in Parkinson’s disease

Bereitschaftspotential preceding eyelid blinks in Parkinson’s disease

ABSTRACT The Bereitschaftspotential (BP) is a negative wave observed in EEG retrograde averaging, preceding a motor act. The objective was to study the BP preceding voluntary eyelid blinks in Parkinson’s disease (PD) patients during off and on phases of levodopa. Methods Ten PD patients in stages...

Full description

Bibliographic Details
Main Authors:	Isabella Araújo Mota, Maria das Graças Coriolano, Otávio Gomes Lins
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO)
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	contingent negative variation Parkinson disease levodopa
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800539&lng=en&tlng=en

Similar Items

Verificação dos efeitos da Levodopa na deglutição de pacientes com doença de Parkinson
by: Douglas Monteiro, et al.
Published: (2014-03-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Sleep disturbances in drug naïve Parkinson′s disease (PD) patients and effect of levodopa on sleep
by: Teresa Ferreira, et al.
Published: (2014-01-01)

How I treat Parkinson's disease
by: Egberto Reis Barbosa, et al.
Published: (2022-08-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Levodopa for treatment of parkinson’s disease
by: M. Petraru, et al.
Published: (2011-09-01)

Investigation of <i>PRKN</i> Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
by: Ana Gabrielle Bispo, et al.
Published: (2023-08-01)

Vascular parkinsonism: A review on management updates
by: Thilini B Udagedara, et al.
Published: (2019-01-01)

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence
by: Ritam Bandopadhyay, et al.
Published: (2022-04-01)

Apraxia of eyelid opening might be critical for levodopa-carbidopa intestinal gel treatment
by: Hiroshi Kataoka, et al.
Published: (2020-01-01)

Dynamics of levodopa-therapy in patients with Parkinson’s disease afterunilateral pallidotomy
by: V.I. Tsymbaliuk, et al.
Published: (2018-12-01)

Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease
by: Dan Su, et al.
Published: (2023-07-01)

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

Dopaminergic medication modulates learning from feedback and error-related negativity in Parkinson’s disease: a pilot study
by: Chiara Volpato, et al.
Published: (2016-10-01)

Bereitschaftspotential in Multiple System Atrophy
by: Yi-Chien Yang, et al.
Published: (2021-06-01)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
by: Hesna Bektaş, et al.
Published: (2014-04-01)

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial
by: Aryun Kim, et al.
Published: (2018-05-01)

Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
by: Sanju P Joy, et al.
Published: (2015-01-01)

Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test
by: Xiaoqin He, et al.
Published: (2022-01-01)

Investigation of the Association of Homocysteine and MTHFR Polymorphisms and Treatment Options in Parkinson’s Disease in Central Anatolian Region*
by: Ramazan Emre, et al.
Published: (2015-12-01)

Malignant Syndrome in a Patient with Parkinson's Disease
by: Nesrin Helvacı Yılmaz, et al.
Published: (2012-09-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
by: Daniël van Poppelen, et al.
Published: (2021-06-01)

The overview of the therapeutic strategy for motor complications of Parkinson's disease
by: Ying WAN, et al.
Published: (2013-08-01)

Effect of daidzein on Parkinson disease induced by reserpine in rats
by: Radha Goel, et al.
Published: (2020-04-01)

The risk of developing motor complications with Levodopa immediate versus dual release upon treatment initiation in Parkinson’s disease
by: Christian Ineichen, et al.
Published: (2023-01-01)

A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
by: A Ahmadi Ahangar, et al.
Published: (2002-07-01)

Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
by: Vinod Metta, et al.
Published: (2020-01-01)

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
by: K. Amande M. Pauls, et al.
Published: (2021-12-01)

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
by: Kye Won Park, et al.
Published: (2020-09-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Validating the Vietnamese version of wearing – Off 19 questionnaire for patients with Parkinson's disease
by: Uyen Le Ngoc Ha, et al.
Published: (2019-01-01)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
by: Werner Poewe, et al.
Published: (2010-08-01)

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
by: Szász JA, et al.
Published: (2019-04-01)

Lo Nuevo ante la Enfermedad de Parkinson
by: Juan Mendoza Vega
Published: (1990-12-01)

Comparison of the clinical response of stereotactic ventrointermedial thalamotomy with anatomical and pathophysiological features of parkinson's disease
by: VI. Tsymbaliuk, et al.
Published: (2017-12-01)

EEG Microstates Change in Response to Increase in Dopaminergic Stimulation in Typical Parkinson’s Disease Patients
by: J. Ignacio Serrano, et al.
Published: (2018-10-01)

An interesting case of Parkinsonism in the young
by: Akula Sushmitha, et al.
Published: (2022-01-01)

A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies
by: James T. Boyd, et al.
Published: (2020-01-01)

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients
by: Szász JA, et al.
Published: (2019-11-01)